113.68
price down icon2.26%   -2.62
 
loading
Schlusskurs vom Vortag:
$116.30
Offen:
$112.66
24-Stunden-Volumen:
6,604
Relative Volume:
0.01
Marktkapitalisierung:
$6.45B
Einnahmen:
$738.26M
Nettoeinkommen (Verlust:
$48.89M
KGV:
131.50
EPS:
0.8645
Netto-Cashflow:
$91.69M
1W Leistung:
-3.35%
1M Leistung:
-14.95%
6M Leistung:
-9.50%
1J Leistung:
-18.47%
1-Tages-Spanne:
Value
$112.66
$115.08
1-Wochen-Bereich:
Value
$111.92
$122.00
52-Wochen-Spanne:
Value
$102.97
$175.77

Repligen Corp Stock (RGEN) Company Profile

Name
Firmenname
Repligen Corp
Name
Telefon
(781) 449-9560
Name
Adresse
41 SEYON STREET, WALTHAM, MA
Name
Mitarbeiter
2,000
Name
Twitter
@repligen
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
RGEN's Discussions on Twitter

Compare RGEN vs ISRG, BDX, ALC, MDLN, RMD

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
RGEN icon
RGEN
Repligen Corp
114.43 6.44B 738.26M 48.89M 91.69M 0.8645
ISRG icon
ISRG
Intuitive Surgical Inc
468.48 166.92B 10.06B 2.88B 2.49B 7.876
BDX icon
BDX
Becton Dickinson Co
157.72 45.02B 21.92B 1.76B 2.63B 6.1223
ALC icon
ALC
Alcon Inc
75.28 36.68B 10.40B 980.00M 1.61B 1.9749
MDLN icon
MDLN
Medline Inc
42.32 34.63B 28.43B 1.16B 1.26B 1.4457
RMD icon
RMD
Resmed Inc
225.56 32.97B 5.40B 1.49B 1.78B 10.12

Repligen Corp Stock (RGEN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-01 Eingeleitet HSBC Securities Buy
2025-09-22 Hochstufung Evercore ISI In-line → Outperform
2025-07-22 Fortgesetzt Stephens Overweight
2025-06-24 Eingeleitet Barclays Overweight
2025-04-29 Hochstufung Wolfe Research Peer Perform → Outperform
2025-03-18 Eingeleitet Evercore ISI In-line
2025-02-10 Eingeleitet TD Cowen Buy
2024-12-17 Eingeleitet Canaccord Genuity Hold
2024-11-14 Eingeleitet Wolfe Research Peer Perform
2024-08-28 Eingeleitet Wells Fargo Overweight
2024-06-26 Hochstufung Deutsche Bank Hold → Buy
2024-06-18 Eingeleitet Guggenheim Neutral
2023-12-04 Herabstufung The Benchmark Company Buy → Hold
2023-07-20 Eingeleitet Wells Fargo Overweight
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-03-28 Eingeleitet The Benchmark Company Buy
2022-12-14 Eingeleitet Deutsche Bank Hold
2022-12-07 Eingeleitet RBC Capital Mkts Sector Perform
2022-07-20 Eingeleitet UBS Buy
2021-10-14 Eingeleitet Exane BNP Paribas Outperform
2020-11-10 Eingeleitet KeyBanc Capital Markets Overweight
2020-08-24 Bestätigt H.C. Wainwright Buy
2020-06-30 Bestätigt H.C. Wainwright Buy
2020-05-07 Bestätigt H.C. Wainwright Buy
2020-03-23 Bestätigt H.C. Wainwright Buy
2019-11-15 Eingeleitet Stifel Buy
2019-11-01 Hochstufung First Analysis Sec Outperform → Strong Buy
2019-10-15 Eingeleitet SVB Leerink Outperform
2019-08-28 Bestätigt First Analysis Sec Outperform
2019-08-23 Fortgesetzt Stephens Overweight
2019-07-22 Hochstufung H.C. Wainwright Neutral → Buy
2018-12-17 Hochstufung CL King Neutral → Buy
2018-11-12 Herabstufung CL King Buy → Neutral
2018-09-26 Eingeleitet H.C. Wainwright Neutral
2017-12-08 Eingeleitet Citigroup Buy
2017-12-05 Eingeleitet JP Morgan Overweight
2017-11-13 Eingeleitet CL King Buy
2017-10-02 Hochstufung First Analysis Sec Equal-Weight → Overweight
2017-07-21 Eingeleitet William Blair Outperform
2017-02-13 Hochstufung Piper Jaffray Neutral → Overweight
Alle ansehen

Repligen Corp Aktie (RGEN) Neueste Nachrichten

pulisher
Mar 24, 2026

E. Ohman J or Asset Management AB Takes Position in Repligen Corporation $RGEN - MarketBeat

Mar 24, 2026
pulisher
Mar 23, 2026

Repligen (RGEN) SVP R&D Ralf Kuriyel receives new stock options and RSUs - Stock Titan

Mar 23, 2026
pulisher
Mar 23, 2026

Repligen (RGEN) CEO receives 25,890 options and 24,134 RSUs - Stock Titan

Mar 23, 2026
pulisher
Mar 23, 2026

Repligen (NASDAQ: RGEN) COO granted options and 7,751 RSUs - Stock Titan

Mar 23, 2026
pulisher
Mar 23, 2026

Repligen (RGEN) CFO awarded stock options and 7,751 restricted stock units - Stock Titan

Mar 23, 2026
pulisher
Mar 23, 2026

RGEN: HC Wainwright & Co. Raises Price Target for Repligen | RGE - GuruFocus

Mar 23, 2026
pulisher
Mar 23, 2026

H.C. Wainwright raises Repligen stock price target on strong growth By Investing.com - Investing.com Canada

Mar 23, 2026
pulisher
Mar 23, 2026

Repligen (NASDAQ:RGEN) Price Target Raised to $208.00 - MarketBeat

Mar 23, 2026
pulisher
Mar 23, 2026

Is Repligen (NASDAQ:RGEN) Influenced By Nasdaq Index Volatility? - Kalkine Media

Mar 23, 2026
pulisher
Mar 22, 2026

Hudson Bay Capital Management LP Invests $2.81 Million in Repligen Corporation $RGEN - MarketBeat

Mar 22, 2026
pulisher
Mar 21, 2026

Repligen Conference: CEO touts differentiated bioprocessing portfolio; CFO targets 30% EBITDA margin - Yahoo Finance

Mar 21, 2026
pulisher
Mar 21, 2026

Republic Services Inc stock shines with eighth World's Most Ethical Companies honor and analyst upgr - AD HOC NEWS

Mar 21, 2026
pulisher
Mar 21, 2026

Repligen Corp stock drops 3.17% on NASDAQ amid biotech sector pressures and upcoming earnings - AD HOC NEWS

Mar 21, 2026
pulisher
Mar 19, 2026

Repligen Earnings Beat Puts Focus On Analytics Growth And Rich Valuation - Yahoo Finance

Mar 19, 2026
pulisher
Mar 17, 2026

Alliancebernstein L.P. Buys 197,778 Shares of Repligen Corporation $RGEN - MarketBeat

Mar 17, 2026
pulisher
Mar 16, 2026

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack - Yahoo Finance

Mar 16, 2026
pulisher
Mar 16, 2026

270,000 Shares in Repligen Corporation $RGEN Acquired by Iron Triangle Partners LP - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Fred Alger Management LLC Boosts Position in Repligen Corporation $RGEN - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Repligen Corporation $RGEN Shares Acquired by Bamco Inc. NY - MarketBeat

Mar 16, 2026
pulisher
Mar 11, 2026

Schroder Investment Management Group Purchases 254,212 Shares of Repligen Corporation $RGEN - MarketBeat

Mar 11, 2026
pulisher
Mar 11, 2026

Repligen Corporation $RGEN Shares Sold by Blue Whale Capital LLP - MarketBeat

Mar 11, 2026
pulisher
Mar 11, 2026

Repligen Corp at Leerink Global Healthcare Conference Transcript - GuruFocus

Mar 11, 2026
pulisher
Mar 10, 2026

Repligen at Leerink Conference: Strategic Growth and Challenges - Investing.com

Mar 10, 2026
pulisher
Mar 08, 2026

Reassessing Repligen (RGEN) Valuation After Sector Pullback And Profitability Concerns - Yahoo Finance

Mar 08, 2026
pulisher
Mar 08, 2026

Evaluating Repligen (RGEN) After Sharp Share Price Declines and Conflicting Valuation Signals - Yahoo Finance

Mar 08, 2026
pulisher
Mar 08, 2026

Reassessing Repligen (RGEN) Valuation After Healthcare Jobs Shock And Margin Concerns - simplywall.st

Mar 08, 2026
pulisher
Mar 08, 2026

Market Moves: Whats the analyst consensus on Repligen Corporation2026 Sentiment & Expert Approved Trade Ideas - baoquankhu1.vn

Mar 08, 2026
pulisher
Mar 06, 2026

AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance

Mar 06, 2026
pulisher
Mar 05, 2026

Repligen Corporation to Present at Upcoming March Conferences - ChartMill

Mar 05, 2026
pulisher
Mar 05, 2026

Bioprocessing firm Repligen fields CEO, CFO at three March investor conferences - Stock Titan

Mar 05, 2026
pulisher
Mar 04, 2026

RGEN SEC FilingsRepligen 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Repligen Corporation $RGEN Shares Sold by TD Asset Management Inc - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

NZS Capital LLC Has $26.30 Million Stake in Repligen Corporation $RGEN - MarketBeat

Mar 04, 2026
pulisher
Mar 03, 2026

Repligen (RGEN) COO uses 3,911 shares to cover tax withholding - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Repligen (RGEN) CEO reports tax-withholding share dispositions in Form 4 - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Repligen (RGEN) director uses 9,897 shares to cover RSU taxes - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Repligen (RGEN) CFO stock withheld to cover RSU tax obligations - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Repligen (RGEN) SVP uses company shares to cover RSU taxes - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Repligen (RGEN) CPO has shares withheld to cover RSU tax bill - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

3 Reasons to Avoid RGEN and 1 Stock to Buy Instead - Yahoo Finance

Mar 03, 2026
pulisher
Mar 02, 2026

Repligen Corporation (RGEN) Investor Outlook: Exploring a 44.7% Potential Upside in the Bioprocessing Sector - DirectorsTalk Interviews

Mar 02, 2026
pulisher
Mar 02, 2026

Repligen Corporation $RGEN Position Boosted by Royce & Associates LP - MarketBeat

Mar 02, 2026
pulisher
Mar 01, 2026

Artisan Partners Limited Partnership Has $28.44 Million Stock Holdings in Repligen Corporation $RGEN - MarketBeat

Mar 01, 2026
pulisher
Feb 28, 2026

Primecap Management Co. CA Has $24.98 Million Stock Position in Repligen Corporation $RGEN - MarketBeat

Feb 28, 2026
pulisher
Feb 28, 2026

Repligen (NASDAQ:RGEN) Downgraded to Hold Rating by Wall Street Zen - MarketBeat

Feb 28, 2026
pulisher
Feb 27, 2026

Privia Health, Repligen, and RadNet Shares Plummet, What You Need To Know - Yahoo Finance

Feb 27, 2026
pulisher
Feb 27, 2026

Repligen Corp (RGEN) Shares Down 3.09% on Feb 27 - GuruFocus

Feb 27, 2026
pulisher
Feb 27, 2026

Oversold Conditions For Repligen (RGEN) - Nasdaq

Feb 27, 2026
pulisher
Feb 27, 2026

Decoding Repligen Corp (RGEN): A Strategic SWOT Insight - GuruFocus

Feb 27, 2026
pulisher
Feb 26, 2026

Repligen (NASDAQ: RGEN) maps 2025 bioprocessing market, debt and control risks - Stock Titan

Feb 26, 2026
pulisher
Feb 25, 2026

A Glimpse Into The Expert Outlook On Repligen Through 6 Analysts - Benzinga

Feb 25, 2026

Finanzdaten der Repligen Corp-Aktie (RGEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Repligen Corp-Aktie (RGEN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
MUIR GLENN P
Director
Dec 16 '25
Option Exercise
26.12
3,366
87,920
36,622
$64.60
price down icon 0.03%
$178.81
price down icon 0.86%
COO COO
$71.47
price up icon 0.36%
$75.59
price up icon 0.09%
WST WST
$244.72
price up icon 0.00%
RMD RMD
$226.57
price down icon 0.68%
Kapitalisierung:     |  Volumen (24h):